FDA Adverse Event Malfunction Summary report: N

PIPELINE FLEX W/SHIELD TECHNOLOGY

MDR report key: 25186008 · Received May 15, 2026

Report

Report Number
2029214-2026-00893
Event Type
Malfunction
Date Received
May 15, 2026
Date of Event
May 8, 2026
Report Date
May 15, 2026
Manufacturer
MICRO THERAPEUTICS, INC. DBA EV3
Product Code
OUT
UDI-DI
00847536002661
PMA / PMN Number
P100018
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
UK
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

CONTINUATION OF D10: PRODUCT ID: PED2-500-16, (D022700); PRODUCT ID: PED2-500-14, (D022996); MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. MEDTRONIC WILL SUBMIT A SUPPLEMENTAL REPORT IF ADDITIONAL RELEVANT INFORMATION BECOMES KNOWN.

Description of Event or Problem · 0

MEDTRONIC RECEIVED INFORMATION REGARDING THREE PIPELINE FLEX WITH SHIELD STENTS THAT FAILED TO OPEN. THE PATIENT WAS UNDERGOING A PROCEDURE FOR FLOW DIVERTER TREATMENT OF AN UNRUPTURED SACCULAR ANEURYSM. PATIENT'S VESSEL TORTUOSITY WAS MODERATE. IT WAS REPORTED THAT THE DEVICES WERE PREPARED AS INDICATED IN THE INSTRUCTIONS FOR USE (IFU). THE PIPELINE WAS DIFFICULT TO OPEN AROUND THE VESSEL BEND(S) AND WAS DEFORMED. THE SAME ISSUE OCCURRED WITH THREE PIPELINES. THE PROCEDURE WAS ULTIMATELY ABANDONED. THE PATIENT HAD NO SYMPTOMS OR COMPLICATIONS ASSOCIATED WITH THIS EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
513466 PIPELINE FLEX W/SHIELD TECHNOLOGY INTRACRANIAL ANEURYSM FLOW DIVERTER OUT MICRO THERAPEUTICS, INC. DBA EV3 PED2-500-18 B675662 00847536002661

Patients

Seq Age Sex Outcome Treatment
1